265 related articles for article (PubMed ID: 36979639)
1. Regulation of ErbB Receptors by the Ca
Villalobo A
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979639
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of the erbB gene family calmodulin-binding and calmodulin-like domains in astrocytic gliomas.
Arjona D; Bello MJ; Alonso ME; Gonzalez-Gomez P; Lomas J; Aminoso C; Lopez-Marin I; Isla A; De Campos JM; Vaquero J; Gutierrez M; Villalobo A; Rey JA
Int J Oncol; 2004 Nov; 25(5):1489-94. PubMed ID: 15492843
[TBL] [Abstract][Full Text] [Related]
3. Targeting of ErbB1, ErbB2, and their Dual Targeting Using Small Molecules and Natural Peptides: Blocking EGFR Cell Signaling Pathways in Cancer: A Mini-Review.
Patnaik SK; Chandrasekar MJN; Nagarjuna P; Ramamurthi D; Swaroop AK
Mini Rev Med Chem; 2022 Oct; 22(22):2831-2846. PubMed ID: 35549881
[TBL] [Abstract][Full Text] [Related]
4. ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma.
Liu S; Geng R; Lin E; Zhao P; Chen Y
Front Genet; 2021; 12():602160. PubMed ID: 33732282
[TBL] [Abstract][Full Text] [Related]
5. ErbB Receptors and Cancer.
Wang Z
Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
[TBL] [Abstract][Full Text] [Related]
6. Peptides for Dual Targeting of ErbB1 and ErbB2: Blocking EGFR Cell Signaling Transduction Pathways for Cancer Chemotherapy.
Patnaik SK; Swaroop AK; Nagarjuna P; Nanjan MJ; Chandrasekar MJN
Curr Mol Pharmacol; 2024; 17(1):e240223214012. PubMed ID: 36843255
[TBL] [Abstract][Full Text] [Related]
7. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
8. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
9. The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein.
Li H; Sánchez-Torres J; Del Carpio A; Salas V; Villalobo A
Biochem J; 2004 Jul; 381(Pt 1):257-66. PubMed ID: 15080792
[TBL] [Abstract][Full Text] [Related]
10. Role of ErbB Receptors in Cancer Cell Migration and Invasion.
Appert-Collin A; Hubert P; Crémel G; Bennasroune A
Front Pharmacol; 2015; 6():283. PubMed ID: 26635612
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the ligand-dependent activation of the epidermal growth factor receptor by calmodulin.
Li H; Panina S; Kaur A; Ruano MJ; Sánchez-González P; la Cour JM; Stephan A; Olesen UH; Berchtold MW; Villalobo A
J Biol Chem; 2012 Jan; 287(5):3273-81. PubMed ID: 22157759
[TBL] [Abstract][Full Text] [Related]
13. Targeting the calmodulin-regulated ErbB/Grb7 signaling axis in cancer therapy.
Villalobo A; García-Palmero I; Stateva SR; Jellali K
J Pharm Pharm Sci; 2013; 16(2):177-89. PubMed ID: 23958188
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients.
Sassen A; Rochon J; Wild P; Hartmann A; Hofstaedter F; Schwarz S; Brockhoff G
Breast Cancer Res; 2008; 10(1):R2. PubMed ID: 18182100
[TBL] [Abstract][Full Text] [Related]
15. Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.
Pellat A; Vaquero J; Fouassier L
Hepatology; 2018 Feb; 67(2):762-773. PubMed ID: 28671339
[TBL] [Abstract][Full Text] [Related]
16. Targeting ErbB receptors in high-grade glioma.
Berezowska S; Schlegel J
Curr Pharm Des; 2011; 17(23):2468-87. PubMed ID: 21827413
[TBL] [Abstract][Full Text] [Related]
17. Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.
Mill CP; Gettinger KL; Riese DJ
Exp Cell Res; 2011 Feb; 317(4):392-404. PubMed ID: 21110957
[TBL] [Abstract][Full Text] [Related]
18. Calmodulin binds HER2 and modulates HER2 signaling.
White CD; Li Z; Sacks DB
Biochim Biophys Acta; 2011 May; 1813(5):1074-82. PubMed ID: 21185879
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Protein Levels of the Receptor Tyrosine Kinase ErbB3 in Serum.
D'Abronzo LS; Pan CX; Ghosh PM
Methods Mol Biol; 2018; 1655():319-334. PubMed ID: 28889394
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]